iRhythm grants performance-based RSUs to top executives with target shares and three-year goals

iRhythm Holdings, Inc.

CEO Blackford granted 48,534 target PSUs; CFO, CBLO, CCO, CMO each 13,589 target PSUs.
PSUs vest based on three equally weighted operational goals: patient registrations, adjusted EBITDA margin, product innovations over July 2023-June 2026.
Earned PSUs adjusted by TSR vs. S&P Healthcare Equipment Select Index; upward/downward 25% depending on percentile.
Maximum vesting at 150% of target if all three goals achieved and TSR above 75th percentile (capped).
Other management team members received aggregate 19,364 target PSUs under same program.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.